
Sarah Sammons/medicine.duke.edu
Apr 8, 2025, 09:45
Sarah Sammons: How does Sacituzumab Govitecan perform in active BC brain metastases?
Sarah Sammons, Breast Medical Oncologist at Dana-Farber Cancer Institute, shared a post on X:
“How does SG perform in Active BC brain metastases?
33 patients with HER2-negative MBC and CNS metastases.
CNS ORR = 4/30 (13%)
Median CNS-progression-free survival=2.9 months (95%CI:2.0–4.3)
Huge area of unmet need.”
Authors: Thomas Grinda, Sarah Sammons et al.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 15, 2025, 17:01
Apr 15, 2025, 16:16
Apr 15, 2025, 15:50
Apr 15, 2025, 15:31
Apr 15, 2025, 15:26
Apr 15, 2025, 15:10